Ximin Li

Ximin Li currently serves as the Sr. Director at Avid/Eli Lilly since October 2022 and has held the position of Principal Research Scientist at Avid/Eli Lilly & Co. since March 2018. With a tenure at Avid Radiopharmaceuticals starting in October 2009, Ximin Li has contributed as a Senior Research Chemist and previously as a Research Chemist, focusing on the development of novel PET radiotracers for neurodegenerative diseases. Prior experience includes a role as a Postdoctoral Research Associate at the University of Pennsylvania, specializing in the synthesis of complex organic compounds, and as a Research Scientist at Red Sun Group Corporation, where supervision of research specialists and chemical engineers was part of the responsibility. Ximin Li obtained a Postdoc in Organic Chemistry from the University of Pennsylvania, a Ph.D. from Washington University in St. Louis, and a BS and MS in Chemistry from Nanjing University of Science and Technology.